Mondaq Canada: Food, Drugs, Healthcare, Life Sciences
Dickinson Wright PLLC
The Safe Foods for Canadian Act (the Act) received Royal Assent in November 2012 and is anticipated to start taking effect at the beginning of 2015.
TTL Health Law
Earlier this year, the legislative framework surrounding the provision of medical marijuana in Canada underwent significant change.
Collins Barrow National Incorporated
While the majority of Canadians will not notice any impact as a result of the Affordable Health Care Act, commonly known as Obamacare, a select few may need to comply with its rules.
Gowling Lafleur Henderson LLP
On December 19, 2014, the Federal Court set aside a decision of the Minister of Health granting a Notice of Compliance to Teva authorizing the sale of its product that referred to Pfizer’s Aromasin®.
Miller Thomson LLP
Bill 8, the Public Sector Accountability and MPP Accountability and Transparency Act, 2014 passed third reading on December 9, 2014 and received Royal Assent on December 11, 2014.
Norton Rose Fulbright Canada LLP
On November 28, 2014, the Quebec government introduced Bill 20, An Act to Enact the Act to Promote Access to Family Medicine and Specialized Medicine Services and to Amend Various Legislative Provisions relating to Assisted Procreation.
Borden Ladner Gervais LLP
The legislature has significantly expanded a hospital’s duty to report to the College of Physicians and Surgeons of Ontario where there are concerns about physician’s competence, negligence or conduct.
MNP
There’s a lot to consider when you are a micro-brewery, whether you are just starting out or whether you have an established operation.
Norton Rose Fulbright Canada LLP
Bill 28 would allow the Minister of Health and Social Services to enter into "drug listing agreements" directly with manufacturers.
Norton Rose Fulbright Canada LLP
On December 23, 2014, Apotex Inc. and Mylan Pharmaceuticals ULC each filed Supreme Court of Canada applications for leave to appeal the Federal Court of Appeal’s decision in 2014 FCA 250 dated October 30, 2014.
Smart & Biggar/Fetherstonhaugh
The following are highlights of developments in Canadian pharmaceutical intellectual property and regulatory law in 2014.
Miller Thomson LLP
The Saskatchewan Court of Appeal has unanimously rejected the appeal of a Treaty Indian who operates a game farm on reserve lands concerning his conviction for exporting antlers and other wildlife parts.
Osler, Hoskin & Harcourt LLP
In recent years Health Canada has been expanding its legislative and regulatory powers in respect of consumer safety on a number of fronts.
Torkin Manes LLP
For years, opticians and optometrists have been advocating for greater flexibility with respect to their relationships with their counterparts on the other side of the glass.
Norton Rose Fulbright Canada LLP
The Agricultural Growth Act (Bill C-18) was recently passed by Canada's House of Commons and is now in its final stages of becoming law.
Norton Rose Fulbright Canada LLP
Tim Hortons Inc. has agreed to be purchased by Burger King Worldwide, Inc., which would create the third-largest fast food company in the world.
Norton Rose Fulbright Canada LLP
In early December 2014, an outbreak of H5N2 strain of avian influenza was found in BC.
Miller Thomson LLP
Catherine Bate & Kelly Harris have prepared a piece for Global Advertising Lawyers Alliance (GALA) on "New Nutrition Criteria for Food Advertising to Children."
Norton Rose Fulbright Canada LLP
A report from the Patented Medicine Prices Review Board (PMPRB) compares generic drug prices in Canada with those of other industrialized countries.
Miller Thomson LLP
Despite the fact that this is the third ruling the WTO has made against the United States’ meat-labelling laws in five years, the U.S. is appealing this most recent decision.
Latest Video
Most Popular Recent Articles
Davis LLP
In November 2014, the Saskatchewan Information and Privacy Commissioner issued an Investigation Report in a case involving employee "snooping" in personal health records held by the Regina Qu’Appelle Regional Health Authority.
Torkin Manes LLP
For years, opticians and optometrists have been advocating for greater flexibility with respect to their relationships with their counterparts on the other side of the glass.
Gowling Lafleur Henderson LLP
On December 19, 2014, the Federal Court set aside a decision of the Minister of Health granting a Notice of Compliance to Teva authorizing the sale of its product that referred to Pfizer’s Aromasin®.
Cassels Brock
Hello 2015 - From the Cassels Brock Product Liability Group, welcome back and we hope you enjoyed some time off this holiday season.
McMillan LLP
Medical marijuana has been making headlines in Canada after sweeping changes to regulations created a new market for commercial marijuana production.
Osler, Hoskin & Harcourt LLP
In recent years Health Canada has been expanding its legislative and regulatory powers in respect of consumer safety on a number of fronts.
Borden Ladner Gervais LLP
The legislature has significantly expanded a hospital’s duty to report to the College of Physicians and Surgeons of Ontario where there are concerns about physician’s competence, negligence or conduct.
Marsh Canada Ltd
Outbreaks of infectious diseases have increased with the advent of globalization.
Norton Rose Fulbright Canada LLP
On December 23, 2014, Apotex Inc. and Mylan Pharmaceuticals ULC each filed Supreme Court of Canada applications for leave to appeal the Federal Court of Appeal’s decision in 2014 FCA 250 dated October 30, 2014.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners